Cardlytics (CDLX) EBIAT (2017 - 2025)
Historic EBIAT for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$72.7 million.
- Cardlytics' EBIAT rose 4994.35% to -$72.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$110.8 million, marking a year-over-year increase of 5963.32%. This contributed to the annual value of -$189.3 million for FY2024, which is 4053.54% down from last year.
- Per Cardlytics' latest filing, its EBIAT stood at -$72.7 million for Q3 2025, which was up 4994.35% from -$9.3 million recorded in Q2 2025.
- Over the past 5 years, Cardlytics' EBIAT peaked at $33.0 million during Q1 2022, and registered a low of -$378.3 million during Q4 2022.
- Its 5-year average for EBIAT is -$53.3 million, with a median of -$24.0 million in 2023.
- Over the last 5 years, Cardlytics' EBIAT had its largest YoY gain of 23270.94% in 2022, and its largest YoY loss of 309627.38% in 2022.
- Cardlytics' EBIAT (Quarter) stood at -$11.8 million in 2021, then crashed by 3096.27% to -$378.3 million in 2022, then skyrocketed by 73.34% to -$100.8 million in 2023, then surged by 84.54% to -$15.6 million in 2024, then tumbled by 366.18% to -$72.7 million in 2025.
- Its last three reported values are -$72.7 million in Q3 2025, -$9.3 million for Q2 2025, and -$13.3 million during Q1 2025.